Bronchiolitis Obliterans Organizing Pneumonia
|
Background: Organizing pneumonia is characterized by the presence of granulation tissue in the distal air spaces. When associated with granulation tissue in the bronchiolar lumen, organizing pneumonia is qualified by the term bronchiolitis obliterans (BO). Hence, the term bronchiolitis obliterans organizing pneumonia (BOOP) is used. Organizing pneumonia may be classified according to whether (1) its cause is determined, (2) its cause is undetermined but occurring in a specific and relevant context, or (3) it is cryptogenic (idiopathic) organizing pneumonia (COP) (Cordier, 2000). Cryptogenic organizing pneumonia (COP) is often confused with BOOP. COP is a clinicopathologic syndrome characterized by rapid resolution with corticosteroids but frequent relapses when treatment is tapered or stopped. Radiologically identical peripheral airspace consolidation can be seen in patients with chronic eosinophilic pneumonia (CEP) and BOOP. Whereas CEP has a predominant upper-lobe involvement, consolidation in BOOP involves the lower zones to a greater degree, though some patients have pathologic features of both CEP and BOOP. Although the precise diagnosis depends on the analysis of a tissue biopsy specimen, clinicoradiologic features derived during biopsy-based studies may be sufficient. This article discusses BOOP in the general context of organizing pneumonia, combining data as necessary from studies in patients with BOOP or COP. No features distinguish organizing pneumonias of known cause from those of unknown cause (Lohr, 1997).
Pathophysiology: Approximately one half of cases of BOOP are idiopathic (Epler, 1985). A variety of conditions are associated with BOOP as follows:
Cytologic and immunocytologic profile of bronchoalveolar lavage in patients with BOOP:
Frequency:
Mortality/Morbidity: Overall mortality rate in patients with BOOP is 10%. Pulmonary complications occur in 30-60% of patients with HSCT. Complications include BOOP, BO, and idiopathic pneumonia syndrome (IPS). BO and BOOP occur exclusively in patients who have undergone allogenic HSCT, and BO and BOOP have 61% and 21% mortality rates, respectively. Patients with BOOP respond favorably to treatment with steroids, whereas patients with IPS have a 1-year survival rate of less than 15%. Race: No racial predilection exists. Sex: No sex predilection exists. Age: Most patients present at age 40-70 years, but BOOP has been reported in children, particularly in children with underlying malignancy. Clinical Details: Approximately one half of patients give a history of an influenzalike illness followed by a short illness of approximately 3 months' (1-4 mo) duration characterized by a persistent nonproductive cough, effort dyspnea, low-grade pyrexia, malaise, and weight loss. Less common symptoms include pleuritic chest pain and hemoptysis. Symptoms do not respond to broad-spectrum antibiotics. A significant number of patients have associated collagen vascular disease (16%) and inhalation exposure to toxins (17%). BOOP may be the first manifestation of non-Hodgkin lymphoma and collagen vascular disease. Clinical examination of the thorax reveals fine, dry, lung crepitations in 70-90% of patients. Clubbing is unusual. The erythrocyte sedimentation rate is invariably increased and may be very high. Pulmonary function tests characteristically show a restrictive pattern. The diffusing capacity (DLCO) is reduced, the resting alveolar arterial oxygen gradient is widened, and exercise-related hypoxemia is present. By contrast, CEP involves an obstructive pattern of lung physiology. Preferred Examination: Plain radiography is usually the initial examination, as in most cases of suspected pulmonary pathology. However, CT scans provide a better assessment of the disease pattern and distribution; therefore, CT is superior to chest radiography in determining the optimal biopsy site. Limitations of Techniques: Plain radiographic and CT findings are nonspecific in patients with BOOP and may mimic those of a variety of pulmonary fibrotic, inflammatory, and neoplastic processes. DIFFERENTIALS Wegener Granulomatosis, Thoracic
Chronic interstitial pneumonia (organizing interstitial pneumonia,
chronic diffuse sclerosing alveolitis)
X-RAY Findings: Plain radiograph findings include the following:
Degree of Confidence: No radiographic features are diagnostic of BOOP. False Positives/Negatives: Mimics of BOOP include collagen vascular disease, usual interstitial pneumonia, lung metastases, Wegener granulomatosis, eosinophilic pneumonia, primary bronchogenic neoplasm, and tuberculosis. In one report, 2 patients with subacute symptoms and signs compatible with pulmonary tuberculosis had cavitary infiltrates in the right upper lobe, as demonstrated on chest radiographs. Histologic analysis of specimens from both patients yielded typical histologic features of BOOP. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
CAT SCAN Findings: CT and high-resolution CT findings include the following:
Degree of Confidence: Plain radiographic and CT findings are nonspecific in BOOP and may be seen in a variety of pulmonary infectious or inflammatory processes and neoplastic diseases. However, CT is more sensitive than chest radiography in the assessment of disease pattern and distribution of disease. CT is superior in determining the biopsy site; therefore, high-resolution computed tomography (HRCT) is usually performed prior to lung biopsy. In the early stages, clinical and chest radiographic findings of acute AIP and BOOP may be similar; however, HRCT findings of AIP and BOOP may be different. Traction bronchiectasis, interlobular septal thickening, and intralobular septal thickening are significantly more prevalent in patients with AIP than in patients with BOOP, whereas parenchymal nodules and peripheral distribution are more prevalent in BOOP. Areas with ground-glass attenuation, airspace consolidation, and architectural distortion are common in both AIP and BOOP. False Positives/Negatives: False-positive diagnosis of BOOP may occur with a variety of pulmonary pathologies. Interstitial lung disease is clinically characterized by diffuse pulmonary infiltrates. The term interstitial is actually a misnomer because it implies that the disease process is confined to the area between the alveolar epithelium and the capillary endothelial basement membrane. In fact, the group of conditions termed interstitial frequently involves the alveolar epithelium, alveolar space, pulmonary microvasculature, respiratory bronchioles, larger airways, and even the pleura. These features add to the nonspecificity of the radiographic findings. The enormous list of interstitial lung diseases may be made manageable by reviewing the patient’s history, by testing for specific serologic measures, and by bronchoalveolar lavage, transbronchial biopsy, biopsy of extrathoracic tissues, or open lung biopsy. Radiographic findings serve as a guide for further investigation. The lack of honeycombing or an irregular reticular pattern in BOOP may help to differentiate BOOP from other interstitial lung disease. Unilobar consolidation may be mistaken for lung malignancy. Identical peripheral airspace consolidation can be seen in CEP and BOOP. Whereas CEP has a predominant upper-lobe involvement, the consolidation in BOOP involves the lower zones to a greater degree, though some patients have pathologic features of both CEP and BOOP. MRI Findings: An early report of the value of gadolinium-enhanced MRI in the evaluation of disease activity in chronic infiltrative lung diseases showed promising results. The cohort of 25 patients included patients with sarcoidosis, BOOP, usual interstitial pneumonia, radiation pneumonitis, desquamative interstitial pneumonia, rheumatoid lung, vasculitis, alveolar proteinosis, bronchoalveolar carcinoma, and/or CEP. Disease activity was assessed by using 1 or more of the following: bronchoalveolar lavage, gallium-67 citrate radionuclide scanning, serum angiotensin-converting enzyme assay, and open lung biopsy. T1-weighted breath-hold MRIs were obtained before and after the intravenous administration of gadolinium-based contrast agent. Of the 17 patients with active disease, 14 had enhancing lesions. At present, MRI has no diagnostic role in BOOP, but it may have a role in the follow-up imaging in patients with BOOP to assess the treatment response or disease activity. Bronchoalveolar carcinoma may mimic BOOP. The white lung sign is an uncommon finding in pulmonary consolidations evaluated with heavily T2-weighted sequences. However, the sign is usually negative in patients with BOOP, but it was found to be positive in 5 of 5 patients with bronchoalveolar carcinoma in one study. Thus, MRI has a potential role in the differential diagnosis of BOOP. ULTRASOUND Findings: Ultrasonography is useful in the detection and characterization of pleural effusion and in the guidance of pleural interventions. INTERVENTION Intervention: Most patients with BOOP require open lung biopsy for diagnosis. However, some evidence suggests that combining the cytologic bronchoalveolar lavage and histologic transbronchial lung biopsy data obtained during a fiberoptic procedure appears to be an effective method for initially investigating BOOP that presents with patchy radiographic shadows. Percutaneous lung biopsy has been used in a few patients, but on the whole, it appears to be inadequate. BOOP may resolve spontaneously; however, patients usually require treatment with steroids. Most patients recover with treatment, and symptoms resolve within days or weeks. Radiographic findings reportedly demonstrate improvement in 50-86% of patients; however, in a minority of patients, the disease may persist. Approximately 30% of patients experience relapse upon withdrawal of treatment. Patients with BOOP respond favorably to treatment with steroids.
PICTURES
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||